Article info

Download PDFPDF

Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies

Authors

  1. a mjreilley{at}mdanderson.org
  2. b amthomas{at}mdanderson.org
  3. c vsubbiah{at}mdanderson.org
  4. d fjanku{at}mdanderson.org
  5. e anaing{at}mdanderson.org
  6. f Gerald.Falchook{at}Healthonecares.com
  7. g dkarp{at}mdanderson.org
  8. h spihapau{at}mdanderson.org
  9. i atsimber{at}mdanderson.org
  10. j siqingfu{at}mdanderson.org
  11. k jlim{at}mdanderson.org
  12. l sbean{at}mdanderson.org
  13. m awalls1{at}mdanderson.org
  14. n smontez{at}mdanderson.org
  15. o lmvence{at}mdanderson.org
  16. p padsharma{at}mdanderson.org
  17. q jallison{at}mdanderson.org
  18. r fmeric{at}mdanderson.org
  19. s (713) 563-5844 dshong{at}mdanderson.org
View Full Text

Citation

Reilley MJ, Bailey A, Subbiah V, et al
Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies

Publication history

  • Received November 18, 2016
  • Accepted March 29, 2017
  • First published April 18, 2017.
Online issue publication 
April 18, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.